The First Year Experience of Newborn Screening for Pompe Disease in California

The First Year Experience of Newborn Screening for Pompe Disease in California

The California Department of Public Health started universal newborn screening for Pompe disease in August 2018 with a two-tier process including: 1) acid alpha-glucosidase (GAA) enzyme activity assay followed by, 2) <i>GAA</i> gene sequencing analysis. This study examines results from t...

Full description

Bibliographic Details
Main Authors:	Hao Tang, Lisa Feuchtbaum, Stanley Sciortino, Jamie Matteson, Deepika Mathur, Tracey Bishop, Richard S. Olney
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	International Journal of Neonatal Screening
Subjects:	pompe disease newborn screening california
Online Access:	https://www.mdpi.com/2409-515X/6/1/9

Similar Items

Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up
by: Jamie Matteson, et al.
Published: (2021-04-01)

Newborn Screening for Pompe Disease: Pennsylvania Experience
by: Can Ficicioglu, et al.
Published: (2020-11-01)

Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
by: David G. Jackson, et al.
Published: (2023-09-01)

Establishing Pompe Disease Newborn Screening: The Role of Industry
by: Joan M. Keutzer
Published: (2020-07-01)

Lessons Learned from Pompe Disease Newborn Screening and Follow-up
by: Tracy L. Klug, et al.
Published: (2020-02-01)

Newborn Screening for Pompe Disease
by: Takaaki Sawada, et al.
Published: (2020-04-01)

At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn Screening
by: Zoltan Lukacs, et al.
Published: (2020-12-01)

Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
by: Kshea Hale, et al.
Published: (2020-06-01)

A Qualitative Study: Mothers’ Experiences of Their Child’s Late-Onset Pompe Disease Diagnosis Following Newborn Screening
by: Kaylee Crossen, et al.
Published: (2022-07-01)

Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I
by: M. Christine Dorley, et al.
Published: (2023-02-01)

Performance of the Four-Plex Tandem Mass Spectrometry Lysosomal Storage Disease Newborn Screening Test: The Necessity of Adding a 2nd Tier Test for Pompe Disease
by: Shu-Chuan Chiang, et al.
Published: (2018-12-01)

Two-Tiered Newborn Screening with Post-Analytical Tools for Pompe Disease and Mucopolysaccharidosis Type I Results in Performance Improvement and Future Direction
by: Patricia L. Hall, et al.
Published: (2020-01-01)

Newborn screening for Pompe disease in Italy: Long-term results and future challenges
by: Vincenza Gragnaniello, et al.
Published: (2022-12-01)

The Impact of Post-Analytical Tools on New York Screening for Krabbe Disease and Pompe Disease
by: Monica M. Martin, et al.
Published: (2020-08-01)

Characteristics of Pompe disease in China: a report from the Pompe registry
by: Yuying Zhao, et al.
Published: (2019-04-01)

A Newborn Screening, Presymptomatically Identified Infant With Late-Onset Pompe Disease: Case Report, Parental Experience, and Recommendations
by: Raymond Y. Wang
Published: (2020-03-01)

The Clinical Management of Pompe Disease: A Pediatric Perspective
by: Jorge Sales Marques
Published: (2022-09-01)

Development of a clinically validated in vitro functional assay to assess pathogenicity of novel GAA variants in patients with Pompe disease identified via newborn screening
by: Shelly Goomber, et al.
Published: (2022-09-01)

Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: Evidence from real-world experiences
by: Yin-Hsiu Chien, et al.
Published: (2020-06-01)

An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion
by: Ryan Colburn, et al.
Published: (2024-01-01)

Newborn Screening for Lysosomal Disease: Mission Creep and a Taste of Things to Come?
by: Bridget Wilcken
Published: (2018-06-01)

A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease
by: Punita Gupta, et al.
Published: (2020-09-01)

Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe Registry
by: Priya S. Kishnani, et al.
Published: (2023-12-01)

Pompe Disease: Early Diagnosis and Early Treatment Make a Difference
by: Yin-Hsiu Chien, et al.
Published: (2013-08-01)

The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California
by: Hao Tang, et al.
Published: (2020-08-01)

Pompe disease in China: clinical and molecular characteristics
by: Jing Li, et al.
Published: (2023-12-01)

Screening for late-onset Pompe disease in Internal Medicine departments in Spain
by: Mónica López-Rodríguez, et al.
Published: (2023-08-01)

2023 APHL/ISNS Newborn Screening Symposium
by: Richard S. Olney, et al.
Published: (2023-10-01)

Late-onset Pompe disease - literature review and summary of current knowledge
by: Karolina Jaskuła, et al.
Published: (2023-01-01)

A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage Disorders
by: Karen A. Sanders, et al.
Published: (2020-05-01)

Light and Shadows in Newborn Screening for Lysosomal Storage Disorders: Eight Years of Experience in Northeast Italy
by: Vincenza Gragnaniello, et al.
Published: (2023-12-01)

AFECTAREA CARDIOVASCULARĂ ÎN BOALA POMPE
by: Alina-Costina Luca, et al.
Published: (2017-03-01)

Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
by: Yvonne Kellar-Guenther, et al.
Published: (2020-04-01)

The Timely Needs for Infantile Onset Pompe Disease Newborn Screening—Practice in Taiwan
by: Shu-Chuan Chiang, et al.
Published: (2020-04-01)

Pharmacological Chaperone Therapy for Pompe Disease
by: Marc Borie-Guichot, et al.
Published: (2021-11-01)

Newborn Screening Program for Oman: The Time is Here and Now
by: Surendra Nath Joshi, et al.
Published: (2012-09-01)

Newborn screening information system
by: Sara Karimi, et al.
Published: (2015-12-01)

Newborn Hearing Screening: Experiences of Different Countries
by: Aurélio, Fernanda Soares, et al.
Published: (2010-09-01)

Hypoglossal neuropathology and respiratory activity in Pompe mice
by: Kun-Ze eLee, et al.
Published: (2011-06-01)

Homozygotic intronic GAA mutation in three siblings with late-onset Pompe's disease Mutação homozigótica intrônica no gene GAA em três irmãos com doença de Pompe de início tardio
by: Anderson Kuntz Grzesiuk, et al.
Published: (2010-04-01)